Ophthalmology

Browse venture capital firms focused on Ophthalmology.

Explore VC firms that invest in Ophthalmology. Filter by country and stage to refine results.

3 of 1354 firms
Filters:
Jeito Capital favicon
Jeito Capital
France

Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.

Founded 2018
Investment Stages
Series A
Series B
Markets
Biopharmaceuticals
Oncology
Ophthalmology
Rare Skeletal Diseases
Severe Respiratory Diseases
Fibrosis
Immuno-oncology
Cardiovascular Disease
Immuno-Oncology Therapies
Auto-Immune Diseases
Neuromuscular Diseases
Cell Therapy
Gene Therapy
Syncona favicon
Syncona
United Kingdom, Guernsey

Syncona is a FTSE250 company focused on founding, building, and funding healthcare companies. They aim to deliver transformational treatments for patients in areas of high unmet need, building a diversified portfolio of 20-25 globally leading life science businesses.

Founded 2012
Investment Stages
Series A
Series B
Series C
Markets
Oncology
Ophthalmology
Cell therapy
Gene therapy
Renal
Cardioprotection
Immunology
Rare diseases
Visionary Ventures favicon
Visionary Ventures
United States

Visionary Ventures is a venture capital fund investing in life sciences, ophthalmology, and medical aesthetics. They focus on early and late-stage investments, from Series A rounds through commercialization, with a target investment range of $5M to $15M. Their unique approach leverages partnerships with Key Opinion Leaders (KOLs) to enhance investment insights and reduce risk.

Founded 2016
Investment Stages
Series A
Series B
Markets
Ophthalmology
Medical Aesthetics
Life Sciences